The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nano-Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Nano-Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Nano-Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Cancer and Tumors accounting for % of the Nano-Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Liposomes segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Nano-Drug include Merck, Pfizer, Novartis, Abbott, and GlaxoSmithKline, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Nano-Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Liposomes
Polymeric Micelles
Solid lipid Nanoparticles
Microemulsion and Nanoemulsion
Nanosuspension
Market segment by Application can be divided into
Cancer and Tumors
Autoimmune Disorders
The key market players for global Nano-Drug market are listed below:
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nano-Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nano-Drug, with price, sales, revenue and global market share of Nano-Drug from 2019 to 2022.
Chapter 3, the Nano-Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nano-Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Nano-Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nano-Drug.
Chapter 13, 14, and 15, to describe Nano-Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Nano-Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Nano-Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Cancer and Tumors accounting for % of the Nano-Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Liposomes segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Nano-Drug include Merck, Pfizer, Novartis, Abbott, and GlaxoSmithKline, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Nano-Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Liposomes
Polymeric Micelles
Solid lipid Nanoparticles
Microemulsion and Nanoemulsion
Nanosuspension
Market segment by Application can be divided into
Cancer and Tumors
Autoimmune Disorders
The key market players for global Nano-Drug market are listed below:
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nano-Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nano-Drug, with price, sales, revenue and global market share of Nano-Drug from 2019 to 2022.
Chapter 3, the Nano-Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nano-Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Nano-Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nano-Drug.
Chapter 13, 14, and 15, to describe Nano-Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Nano-Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nano-Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Liposomes
1.2.3 Polymeric Micelles
1.2.4 Solid lipid Nanoparticles
1.2.5 Microemulsion and Nanoemulsion
1.2.6 Nanosuspension
1.3 Market Analysis by Application
1.3.1 Overview: Global Nano-Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cancer and Tumors
1.3.3 Autoimmune Disorders
1.4 Global Nano-Drug Market Size & Forecast
1.4.1 Global Nano-Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Nano-Drug Sales in Volume (2017-2028)
1.4.3 Global Nano-Drug Price (2017-2028)
1.5 Global Nano-Drug Production Capacity Analysis
1.5.1 Global Nano-Drug Total Production Capacity (2017-2028)
1.5.2 Global Nano-Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nano-Drug Market Drivers
1.6.2 Nano-Drug Market Restraints
1.6.3 Nano-Drug Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Nano-Drug Product and Services
2.1.4 Merck Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Nano-Drug Product and Services
2.2.4 Pfizer Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Nano-Drug Product and Services
2.3.4 Novartis Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Nano-Drug Product and Services
2.4.4 Abbott Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Nano-Drug Product and Services
2.5.4 GlaxoSmithKline Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business
2.6.3 Roche Nano-Drug Product and Services
2.6.4 Roche Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Nano-Drug Product and Services
2.7.4 Sanofi Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business
2.8.3 Eli Lilly Nano-Drug Product and Services
2.8.4 Eli Lilly Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Astrazeneca
2.9.1 Astrazeneca Details
2.9.2 Astrazeneca Major Business
2.9.3 Astrazeneca Nano-Drug Product and Services
2.9.4 Astrazeneca Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson Nano-Drug Product and Services
2.10.4 Johnson & Johnson Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Celgene
2.11.1 Celgene Details
2.11.2 Celgene Major Business
2.11.3 Celgene Nano-Drug Product and Services
2.11.4 Celgene Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Novavax
2.12.1 Novavax Details
2.12.2 Novavax Major Business
2.12.3 Novavax Nano-Drug Product and Services
2.12.4 Novavax Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Stryker
2.13.1 Stryker Details
2.13.2 Stryker Major Business
2.13.3 Stryker Nano-Drug Product and Services
2.13.4 Stryker Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Gilead Sciences
2.14.1 Gilead Sciences Details
2.14.2 Gilead Sciences Major Business
2.14.3 Gilead Sciences Nano-Drug Product and Services
2.14.4 Gilead Sciences Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 OSI Pharmaceuticals
2.15.1 OSI Pharmaceuticals Details
2.15.2 OSI Pharmaceuticals Major Business
2.15.3 OSI Pharmaceuticals Nano-Drug Product and Services
2.15.4 OSI Pharmaceuticals Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Kadmon Pharmaceuticals
2.16.1 Kadmon Pharmaceuticals Details
2.16.2 Kadmon Pharmaceuticals Major Business
2.16.3 Kadmon Pharmaceuticals Nano-Drug Product and Services
2.16.4 Kadmon Pharmaceuticals Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Samyang Biopharm
2.17.1 Samyang Biopharm Details
2.17.2 Samyang Biopharm Major Business
2.17.3 Samyang Biopharm Nano-Drug Product and Services
2.17.4 Samyang Biopharm Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Mitsubishi Pharma
2.18.1 Mitsubishi Pharma Details
2.18.2 Mitsubishi Pharma Major Business
2.18.3 Mitsubishi Pharma Nano-Drug Product and Services
2.18.4 Mitsubishi Pharma Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Kaken Pharmaceutical
2.19.1 Kaken Pharmaceutical Details
2.19.2 Kaken Pharmaceutical Major Business
2.19.3 Kaken Pharmaceutical Nano-Drug Product and Services
2.19.4 Kaken Pharmaceutical Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Selecta Biosciences
2.20.1 Selecta Biosciences Details
2.20.2 Selecta Biosciences Major Business
2.20.3 Selecta Biosciences Nano-Drug Product and Services
2.20.4 Selecta Biosciences Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Par Pharmaceutical
2.21.1 Par Pharmaceutical Details
2.21.2 Par Pharmaceutical Major Business
2.21.3 Par Pharmaceutical Nano-Drug Product and Services
2.21.4 Par Pharmaceutical Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 Cerulean Pharma
2.22.1 Cerulean Pharma Details
2.22.2 Cerulean Pharma Major Business
2.22.3 Cerulean Pharma Nano-Drug Product and Services
2.22.4 Cerulean Pharma Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23 Navidea Biopharmaceuticals
2.23.1 Navidea Biopharmaceuticals Details
2.23.2 Navidea Biopharmaceuticals Major Business
2.23.3 Navidea Biopharmaceuticals Nano-Drug Product and Services
2.23.4 Navidea Biopharmaceuticals Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.24 Lummy
2.24.1 Lummy Details
2.24.2 Lummy Major Business
2.24.3 Lummy Nano-Drug Product and Services
2.24.4 Lummy Nano-Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Nano-Drug Breakdown Data by Manufacturer
3.1 Global Nano-Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Nano-Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Nano-Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Nano-Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Nano-Drug Manufacturer Market Share in 2021
3.5 Global Nano-Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Nano-Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nano-Drug Market Size by Region
4.1.1 Global Nano-Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Nano-Drug Revenue by Region (2017-2028)
4.2 North America Nano-Drug Revenue (2017-2028)
4.3 Europe Nano-Drug Revenue (2017-2028)
4.4 Asia-Pacific Nano-Drug Revenue (2017-2028)
4.5 South America Nano-Drug Revenue (2017-2028)
4.6 Middle East and Africa Nano-Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Nano-Drug Sales in Volume by Type (2017-2028)
5.2 Global Nano-Drug Revenue by Type (2017-2028)
5.3 Global Nano-Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Nano-Drug Sales in Volume by Application (2017-2028)
6.2 Global Nano-Drug Revenue by Application (2017-2028)
6.3 Global Nano-Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Nano-Drug Sales by Type (2017-2028)
7.2 North America Nano-Drug Sales by Application (2017-2028)
7.3 North America Nano-Drug Market Size by Country
7.3.1 North America Nano-Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Nano-Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Nano-Drug Sales by Type (2017-2028)
8.2 Europe Nano-Drug Sales by Application (2017-2028)
8.3 Europe Nano-Drug Market Size by Country
8.3.1 Europe Nano-Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Nano-Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Nano-Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Nano-Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Nano-Drug Market Size by Region
9.3.1 Asia-Pacific Nano-Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Nano-Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Nano-Drug Sales by Type (2017-2028)
10.2 South America Nano-Drug Sales by Application (2017-2028)
10.3 South America Nano-Drug Market Size by Country
10.3.1 South America Nano-Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Nano-Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nano-Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Nano-Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Nano-Drug Market Size by Country
11.3.1 Middle East & Africa Nano-Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Nano-Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Nano-Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Nano-Drug
12.3 Nano-Drug Production Process
12.4 Nano-Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Nano-Drug Typical Distributors
13.3 Nano-Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Nano-Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Nano-Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Nano-Drug Product and Services
Table 6. Merck Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Nano-Drug Product and Services
Table 10. Pfizer Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Major Business
Table 13. Novartis Nano-Drug Product and Services
Table 14. Novartis Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Abbott Basic Information, Manufacturing Base and Competitors
Table 16. Abbott Major Business
Table 17. Abbott Nano-Drug Product and Services
Table 18. Abbott Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Major Business
Table 21. GlaxoSmithKline Nano-Drug Product and Services
Table 22. GlaxoSmithKline Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Roche Basic Information, Manufacturing Base and Competitors
Table 24. Roche Major Business
Table 25. Roche Nano-Drug Product and Services
Table 26. Roche Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Sanofi Basic Information, Manufacturing Base and Competitors
Table 28. Sanofi Major Business
Table 29. Sanofi Nano-Drug Product and Services
Table 30. Sanofi Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 32. Eli Lilly Major Business
Table 33. Eli Lilly Nano-Drug Product and Services
Table 34. Eli Lilly Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 36. Astrazeneca Major Business
Table 37. Astrazeneca Nano-Drug Product and Services
Table 38. Astrazeneca Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 40. Johnson & Johnson Major Business
Table 41. Johnson & Johnson Nano-Drug Product and Services
Table 42. Johnson & Johnson Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Celgene Basic Information, Manufacturing Base and Competitors
Table 44. Celgene Major Business
Table 45. Celgene Nano-Drug Product and Services
Table 46. Celgene Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Novavax Basic Information, Manufacturing Base and Competitors
Table 48. Novavax Major Business
Table 49. Novavax Nano-Drug Product and Services
Table 50. Novavax Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Stryker Basic Information, Manufacturing Base and Competitors
Table 52. Stryker Major Business
Table 53. Stryker Nano-Drug Product and Services
Table 54. Stryker Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 56. Gilead Sciences Major Business
Table 57. Gilead Sciences Nano-Drug Product and Services
Table 58. Gilead Sciences Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. OSI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. OSI Pharmaceuticals Major Business
Table 61. OSI Pharmaceuticals Nano-Drug Product and Services
Table 62. OSI Pharmaceuticals Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Kadmon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Kadmon Pharmaceuticals Major Business
Table 65. Kadmon Pharmaceuticals Nano-Drug Product and Services
Table 66. Kadmon Pharmaceuticals Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Samyang Biopharm Basic Information, Manufacturing Base and Competitors
Table 68. Samyang Biopharm Major Business
Table 69. Samyang Biopharm Nano-Drug Product and Services
Table 70. Samyang Biopharm Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Mitsubishi Pharma Basic Information, Manufacturing Base and Competitors
Table 72. Mitsubishi Pharma Major Business
Table 73. Mitsubishi Pharma Nano-Drug Product and Services
Table 74. Mitsubishi Pharma Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Kaken Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 76. Kaken Pharmaceutical Major Business
Table 77. Kaken Pharmaceutical Nano-Drug Product and Services
Table 78. Kaken Pharmaceutical Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Selecta Biosciences Basic Information, Manufacturing Base and Competitors
Table 80. Selecta Biosciences Major Business
Table 81. Selecta Biosciences Nano-Drug Product and Services
Table 82. Selecta Biosciences Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Par Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 84. Par Pharmaceutical Major Business
Table 85. Par Pharmaceutical Nano-Drug Product and Services
Table 86. Par Pharmaceutical Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. Cerulean Pharma Basic Information, Manufacturing Base and Competitors
Table 88. Cerulean Pharma Major Business
Table 89. Cerulean Pharma Nano-Drug Product and Services
Table 90. Cerulean Pharma Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. Navidea Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Navidea Biopharmaceuticals Major Business
Table 93. Navidea Biopharmaceuticals Nano-Drug Product and Services
Table 94. Navidea Biopharmaceuticals Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 95. Lummy Basic Information, Manufacturing Base and Competitors
Table 96. Lummy Major Business
Table 97. Lummy Nano-Drug Product and Services
Table 98. Lummy Nano-Drug Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 99. Global Nano-Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Doses)
Table 100. Global Nano-Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 101. Market Position of Manufacturers in Nano-Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 102. Global Nano-Drug Production Capacity by Company, (K Doses): 2020 VS 2021
Table 103. Head Office and Nano-Drug Production Site of Key Manufacturer
Table 104. Nano-Drug New Entrant and Capacity Expansion Plans
Table 105. Nano-Drug Mergers & Acquisitions in the Past Five Years
Table 106. Global Nano-Drug Sales by Region (2017-2022) & (K Doses)
Table 107. Global Nano-Drug Sales by Region (2023-2028) & (K Doses)
Table 108. Global Nano-Drug Revenue by Region (2017-2022) & (USD Million)
Table 109. Global Nano-Drug Revenue by Region (2023-2028) & (USD Million)
Table 110. Global Nano-Drug Sales by Type (2017-2022) & (K Doses)
Table 111. Global Nano-Drug Sales by Type (2023-2028) & (K Doses)
Table 112. Global Nano-Drug Revenue by Type (2017-2022) & (USD Million)
Table 113. Global Nano-Drug Revenue by Type (2023-2028) & (USD Million)
Table 114. Global Nano-Drug Price by Type (2017-2022) & (USD/Dose)
Table 115. Global Nano-Drug Price by Type (2023-2028) & (USD/Dose)
Table 116. Global Nano-Drug Sales by Application (2017-2022) & (K Doses)
Table 117. Global Nano-Drug Sales by Application (2023-2028) & (K Doses)
Table 118. Global Nano-Drug Revenue by Application (2017-2022) & (USD Million)
Table 119. Global Nano-Drug Revenue by Application (2023-2028) & (USD Million)
Table 120. Global Nano-Drug Price by Application (2017-2022) & (USD/Dose)
Table 121. Global Nano-Drug Price by Application (2023-2028) & (USD/Dose)
Table 122. North America Nano-Drug Sales by Country (2017-2022) & (K Doses)
Table 123. North America Nano-Drug Sales by Country (2023-2028) & (K Doses)
Table 124. North America Nano-Drug Revenue by Country (2017-2022) & (USD Million)
Table 125. North America Nano-Drug Revenue by Country (2023-2028) & (USD Million)
Table 126. North America Nano-Drug Sales by Type (2017-2022) & (K Doses)
Table 127. North America Nano-Drug Sales by Type (2023-2028) & (K Doses)
Table 128. North America Nano-Drug Sales by Application (2017-2022) & (K Doses)
Table 129. North America Nano-Drug Sales by Application (2023-2028) & (K Doses)
Table 130. Europe Nano-Drug Sales by Country (2017-2022) & (K Doses)
Table 131. Europe Nano-Drug Sales by Country (2023-2028) & (K Doses)
Table 132. Europe Nano-Drug Revenue by Country (2017-2022) & (USD Million)
Table 133. Europe Nano-Drug Revenue by Country (2023-2028) & (USD Million)
Table 134. Europe Nano-Drug Sales by Type (2017-2022) & (K Doses)
Table 135. Europe Nano-Drug Sales by Type (2023-2028) & (K Doses)
Table 136. Europe Nano-Drug Sales by Application (2017-2022) & (K Doses)
Table 137. Europe Nano-Drug Sales by Application (2023-2028) & (K Doses)
Table 138. Asia-Pacific Nano-Drug Sales by Region (2017-2022) & (K Doses)
Table 139. Asia-Pacific Nano-Drug Sales by Region (2023-2028) & (K Doses)
Table 140. Asia-Pacific Nano-Drug Revenue by Region (2017-2022) & (USD Million)
Table 141. Asia-Pacific Nano-Drug Revenue by Region (2023-2028) & (USD Million)
Table 142. Asia-Pacific Nano-Drug Sales by Type (2017-2022) & (K Doses)
Table 143. Asia-Pacific Nano-Drug Sales by Type (2023-2028) & (K Doses)
Table 144. Asia-Pacific Nano-Drug Sales by Application (2017-2022) & (K Doses)
Table 145. Asia-Pacific Nano-Drug Sales by Application (2023-2028) & (K Doses)
Table 146. South America Nano-Drug Sales by Country (2017-2022) & (K Doses)
Table 147. South America Nano-Drug Sales by Country (2023-2028) & (K Doses)
Table 148. South America Nano-Drug Revenue by Country (2017-2022) & (USD Million)
Table 149. South America Nano-Drug Revenue by Country (2023-2028) & (USD Million)
Table 150. South America Nano-Drug Sales by Type (2017-2022) & (K Doses)
Table 151. South America Nano-Drug Sales by Type (2023-2028) & (K Doses)
Table 152. South America Nano-Drug Sales by Application (2017-2022) & (K Doses)
Table 153. South America Nano-Drug Sales by Application (2023-2028) & (K Doses)
Table 154. Middle East & Africa Nano-Drug Sales by Region (2017-2022) & (K Doses)
Table 155. Middle East & Africa Nano-Drug Sales by Region (2023-2028) & (K Doses)
Table 156. Middle East & Africa Nano-Drug Revenue by Region (2017-2022) & (USD Million)
Table 157. Middle East & Africa Nano-Drug Revenue by Region (2023-2028) & (USD Million)
Table 158. Middle East & Africa Nano-Drug Sales by Type (2017-2022) & (K Doses)
Table 159. Middle East & Africa Nano-Drug Sales by Type (2023-2028) & (K Doses)
Table 160. Middle East & Africa Nano-Drug Sales by Application (2017-2022) & (K Doses)
Table 161. Middle East & Africa Nano-Drug Sales by Application (2023-2028) & (K Doses)
Table 162. Nano-Drug Raw Material
Table 163. Key Manufacturers of Nano-Drug Raw Materials
Table 164. Direct Channel Pros & Cons
Table 165. Indirect Channel Pros & Cons
Table 166. Nano-Drug Typical Distributors
Table 167. Nano-Drug Typical Customers
List of Figures
Figure 1. Nano-Drug Picture
Figure 2. Global Nano-Drug Revenue Market Share by Type in 2021
Figure 3. Liposomes
Figure 4. Polymeric Micelles
Figure 5. Solid lipid Nanoparticles
Figure 6. Microemulsion and Nanoemulsion
Figure 7. Nanosuspension
Figure 8. Global Nano-Drug Revenue Market Share by Application in 2021
Figure 9. Cancer and Tumors
Figure 10. Autoimmune Disorders
Figure 11. Global Nano-Drug Revenue, (USD Million) & (K Doses): 2017 & 2021 & 2028
Figure 12. Global Nano-Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Nano-Drug Sales (2017-2028) & (K Doses)
Figure 14. Global Nano-Drug Price (2017-2028) & (USD/Dose)
Figure 15. Global Nano-Drug Production Capacity (2017-2028) & (K Doses)
Figure 16. Global Nano-Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Nano-Drug Market Drivers
Figure 18. Nano-Drug Market Restraints
Figure 19. Nano-Drug Market Trends
Figure 20. Global Nano-Drug Sales Market Share by Manufacturer in 2021
Figure 21. Global Nano-Drug Revenue Market Share by Manufacturer in 2021
Figure 22. Nano-Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Nano-Drug Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Nano-Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Nano-Drug Sales Market Share by Region (2017-2028)
Figure 26. Global Nano-Drug Revenue Market Share by Region (2017-2028)
Figure 27. North America Nano-Drug Revenue (2017-2028) & (USD Million)
Figure 28. Europe Nano-Drug Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Nano-Drug Revenue (2017-2028) & (USD Million)
Figure 30. South America Nano-Drug Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Nano-Drug Revenue (2017-2028) & (USD Million)
Figure 32. Global Nano-Drug Sales Market Share by Type (2017-2028)
Figure 33. Global Nano-Drug Revenue Market Share by Type (2017-2028)
Figure 34. Global Nano-Drug Price by Type (2017-2028) & (USD/Dose)
Figure 35. Global Nano-Drug Sales Market Share by Application (2017-2028)
Figure 36. Global Nano-Drug Revenue Market Share by Application (2017-2028)
Figure 37. Global Nano-Drug Price by Application (2017-2028) & (USD/Dose)
Figure 38. North America Nano-Drug Sales Market Share by Type (2017-2028)
Figure 39. North America Nano-Drug Sales Market Share by Application (2017-2028)
Figure 40. North America Nano-Drug Sales Market Share by Country (2017-2028)
Figure 41. North America Nano-Drug Revenue Market Share by Country (2017-2028)
Figure 42. United States Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Nano-Drug Sales Market Share by Type (2017-2028)
Figure 46. Europe Nano-Drug Sales Market Share by Application (2017-2028)
Figure 47. Europe Nano-Drug Sales Market Share by Country (2017-2028)
Figure 48. Europe Nano-Drug Revenue Market Share by Country (2017-2028)
Figure 49. Germany Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Nano-Drug Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Nano-Drug Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Nano-Drug Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Nano-Drug Revenue Market Share by Region (2017-2028)
Figure 58. China Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Nano-Drug Sales Market Share by Type (2017-2028)
Figure 65. South America Nano-Drug Sales Market Share by Application (2017-2028)
Figure 66. South America Nano-Drug Sales Market Share by Country (2017-2028)
Figure 67. South America Nano-Drug Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Nano-Drug Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Nano-Drug Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Nano-Drug Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Nano-Drug Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Nano-Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Nano-Drug in 2021
Figure 79. Manufacturing Process Analysis of Nano-Drug
Figure 80. Nano-Drug Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
